HOTH — Hoth Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $4.02m
- -$3.54m
- 14
- 49
- 31
- 22
Annual cashflow statement for Hoth Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -7.7 | -7.2 | -14.3 | -11.4 | -7.85 |
| Depreciation | |||||
| Non-Cash Items | 2.59 | 1.2 | 1.69 | 1.48 | 0.146 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.17 | -0.132 | 0.53 | 0.594 | -0.748 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -4.95 | -6.13 | -12.1 | -9.3 | -8.45 |
| Capital Expenditures | -0.095 | -0.167 | -0.117 | -0.074 | 0 |
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.8 | -1.67 | -0.048 | 1.24 | 0 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.895 | -1.84 | -0.165 | 1.16 | 0 |
| Financing Cash Flow Items | 0 | — | — | 0.05 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 7.45 | 8.73 | 18.2 | 6.04 | 11.3 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.61 | 0.739 | 5.91 | -2.11 | 2.86 |